The Peptide Market Hits $46 Billion in 2026 as Regulatory Landscape Shifts

The global peptide therapeutics market reached $46.73 billion in 2026, projected to grow to $83.8 billion by 2035. As the FDA advisory panel's July votes signal a potential regulatory opening for compounded peptides, here's a look at where the market stands and where it's headed.

For research use only. Not for human consumption.